Stern Joel N H, Yaari Gur, Vander Heiden Jason A, Church George, Donahue William F, Hintzen Rogier Q, Huttner Anita J, Laman Jon D, Nagra Rashed M, Nylander Alyssa, Pitt David, Ramanan Sriram, Siddiqui Bilal A, Vigneault Francois, Kleinstein Steven H, Hafler David A, O'Connor Kevin C
Department of Neurology, Yale School of Medicine, New Haven, CT 06511, USA.
Department of Pathology, Yale School of Medicine, New Haven, CT 06511, USA. Bioengineering Program, Faculty of Engineering, Bar-Ilan University, Ramat Gan 52900, Israel.
Sci Transl Med. 2014 Aug 6;6(248):248ra107. doi: 10.1126/scitranslmed.3008879.
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) characterized by autoimmune-mediated demyelination and neurodegeneration. The CNS of patients with MS harbors expanded clones of antigen-experienced B cells that reside in distinct compartments including the meninges, cerebrospinal fluid (CSF), and parenchyma. It is not understood whether this immune infiltrate initiates its development in the CNS or in peripheral tissues. B cells in the CSF can exchange with those in peripheral blood, implying that CNS B cells may have access to lymphoid tissue that may be the specific compartment(s) in which CNS-resident B cells encounter antigen and experience affinity maturation. Paired tissues were used to determine whether the B cells that populate the CNS mature in the draining cervical lymph nodes (CLNs). High-throughput sequencing of the antibody repertoire demonstrated that clonally expanded B cells were present in both compartments. Founding members of clones were more often found in the draining CLNs. More mature clonal members derived from these founders were observed in the draining CLNs and also in the CNS, including lesions. These data provide new evidence that B cells traffic freely across the tissue barrier, with the majority of B cell maturation occurring outside of the CNS in the secondary lymphoid tissue. Our study may aid in further defining the mechanisms of immunomodulatory therapies that either deplete circulating B cells or affect the intrathecal B cell compartment by inhibiting lymphocyte transmigration into the CNS.
多发性硬化症(MS)是一种中枢神经系统(CNS)的炎症性疾病,其特征为自身免疫介导的脱髓鞘和神经退行性变。MS患者的中枢神经系统中存在经历过抗原刺激的B细胞的扩增克隆,这些克隆存在于包括脑膜、脑脊液(CSF)和实质等不同区域。目前尚不清楚这种免疫浸润是在中枢神经系统还是在外周组织中启动其发展过程。脑脊液中的B细胞可与外周血中的B细胞进行交换,这意味着中枢神经系统中的B细胞可能能够进入淋巴组织,而淋巴组织可能是中枢神经系统驻留B细胞遇到抗原并经历亲和力成熟的特定区域。使用配对组织来确定在中枢神经系统中聚集的B细胞是否在引流颈部淋巴结(CLN)中成熟。抗体库的高通量测序表明,两个区域中均存在克隆性扩增的B细胞。克隆的创始成员更常出现在引流CLN中。在引流CLN以及包括病变在内的中枢神经系统中均观察到源自这些创始成员的更成熟的克隆成员。这些数据提供了新的证据,表明B细胞可自由穿过组织屏障,且大多数B细胞成熟发生在中枢神经系统之外的二级淋巴组织中。我们的研究可能有助于进一步明确免疫调节疗法的机制,这些疗法要么消耗循环中的B细胞,要么通过抑制淋巴细胞向中枢神经系统的迁移来影响鞘内B细胞区域。